Profiel
Mark L.
Levitt is currently Director at EnGeneIC Pty Ltd. and Chief Scientific Officer at RedHill Biopharma Ltd. since 2017.
Formerly, Dr. Levitt was Director at UPMC Cancer Institute and Head of the Lung Cancer Unit at Sheba Medical Center.
Actieve functies van Mark Levitt
| Bedrijven | Functie | Begin |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Levitt
| Bedrijven | Functie | Einde |
|---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Directeur/Bestuurslid | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services | Health Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
















